September 12, 2025

Tyra Biosciences, Inc. (TYRA): Investor Outlook Reveals 152.61% Potential Upside

Tyra Biosciences, Inc. (NASDAQ: TYRA) is gaining attention in the biotechnology sector as a key player in the development of precision medicines targeting fibroblast growth factor receptor (FGFR) biology. The..

Ginkgo Bioworks Holdings, Inc. (DNA) Stock Analysis: Navigating Challenges with a Potential 8.56% Upside

Ginkgo Bioworks Holdings, Inc. (NYSE: DNA), a prominent player in the biotechnology sector, is navigating a complex financial landscape with a market capitalization of $618.05 million. Headquartered in Boston, Massachusetts,..

Eton Pharmaceuticals, Inc. (ETON) Stock Analysis: Exploring a 70% Potential Upside in the Rare Disease Sector

Eton Pharmaceuticals, Inc. (NASDAQ: ETON) is capturing the attention of investors with a compelling narrative in the healthcare sector, particularly within the niche of drug manufacturers focusing on specialty and..

Weave Communications, Inc. (WEAV) Stock Analysis: Insights into a High-Growth Healthcare Tech Player with 52.87% Upside Potential

Weave Communications, Inc. (NASDAQ: WEAV), a key player in the Health Information Services industry, is making waves with its innovative customer experience and payments software platform designed for small and..

Akso Health Group (AHG) Investor Outlook: A Closer Look at This Chinese Healthcare Disruptor with Eye-Catching Revenue Growth

Akso Health Group (NASDAQ: AHG), a burgeoning entity within the healthcare sector, has been turning heads with its impressive revenue growth, which has skyrocketed by 415.80%. Operating within the medical..

AxoGen, Inc. (AXGN) Stock Analysis: 47% Potential Upside Beckons Investors

AxoGen, Inc. (NASDAQ: AXGN), a notable player in the healthcare sector specializing in medical devices, is capturing investor attention with its promising outlook and innovative approach to peripheral nerve regeneration..

Akebia Therapeutics, Inc. (AKBA) Investor Outlook: Exploring a Potential 147% Upside

Akebia Therapeutics, Inc. (NASDAQ: AKBA) is capturing investor attention with its promising potential in the healthcare sector, particularly in the niche of kidney disease therapeutics. With a market capitalization of..

uniQure N.V. (QURE) Stock Analysis: Biotechnology Innovator with a Potential 119% Upside

uniQure N.V. (NASDAQ: QURE), a Netherlands-based biotechnology company, is capturing investor attention with its pioneering work in gene therapy. With a market capitalization of $929.45 million, uniQure is positioned at..

Pharvaris N.V. (PHVS) Stock Analysis: Evaluating a 44% Upside in the Biotech Sector

Pharvaris N.V. (PHVS), a biopharmaceutical innovator based in Switzerland, is drawing considerable attention from investors in the biotechnology sector. With a market capitalization of $1.51 billion, Pharvaris is carving out..

Claritev Corporation (CTEV) Investor Outlook: Navigating Healthcare Analytics with a 14.37% Potential Upside

Investors eyeing the healthcare sector might find Claritev Corporation (NASDAQ: CTEV) an intriguing opportunity, especially with its significant potential upside of 14.37% based on current analyst projections. As a player..

Vir Biotechnology, Inc. (VIR) Stock Analysis: Potential 229% Upside Amidst Biotech Challenges

Vir Biotechnology, Inc. (NASDAQ: VIR), a prominent player in the biotechnology sector, is currently navigating a challenging landscape with a substantial promise for future growth. This San Francisco-based company, dedicated..

Capricor Therapeutics, Inc. (CAPR): A Biotechnology Stock with 219.88% Potential Upside

Capricor Therapeutics, Inc. (NASDAQ: CAPR), a clinical-stage biotechnology company, is capturing investor attention with its potential upside of 219.88% based on current analyst ratings. As a key player in the..

Simulations Plus, Inc. (SLP) Stock Analysis: Exploring a 76% Potential Upside with Strong Buy Ratings

Simulations Plus, Inc. (NASDAQ: SLP), a key player in the healthcare sector, specializes in health information services. With a market cap of approximately $289 million, the company stands out for..

Amylyx Pharmaceuticals, Inc. (AMLX) Stock Analysis: A Closer Look at Its 6.63% Potential Upside

Amylyx Pharmaceuticals, Inc. (NASDAQ: AMLX) has been capturing investor attention within the biotechnology sector, with its focus on pioneering treatments for neurodegenerative diseases and endocrine conditions. With a current market..

Geron Corporation (GERN) Stock Analysis: Unveiling a 174% Upside Potential in the Biotech Sector

Geron Corporation (NASDAQ: GERN) is capturing the attention of investors with its promising growth potential in the biotechnology sector. Known for its innovative approach to oncology therapeutics, Geron is making..

Taysha Gene Therapies (TSHA) Stock Analysis: Unraveling the 167% Upside Potential

Taysha Gene Therapies, Inc. (TSHA) is making waves in the biotechnology sector with its ambitious focus on developing adeno-associated virus-based gene therapies aimed at treating monogenic diseases of the central..

Talkspace, Inc. (TALK) Stock Analysis: A Healthcare Innovator with an 84.62% Upside Potential

Talkspace, Inc. (NASDAQ: TALK), a burgeoning player in the healthcare sector, is captivating the attention of investors with its innovative approach to mental health services and a substantial potential upside..

Fulgent Genetics, Inc. (FLGT) Stock Analysis: Navigating a 13.86% Upside Potential Amidst Healthcare Innovation

Fulgent Genetics, Inc. (NASDAQ: FLGT), a prominent player in the healthcare sector under the Diagnostics & Research industry, is capturing investor attention with its potential upside of 13.86%, as reflected..

Day One Biopharmaceuticals, Inc. (DAWN) Stock Analysis: Unveiling a Potential 229% Upside in the Biotech Sector

Day One Biopharmaceuticals, Inc. (NASDAQ: DAWN), a dynamic player in the biotechnology industry, is capturing attention with its impressive potential upside of 229.04%, according to analyst ratings. Based in Brisbane,..

Phibro Animal Health Corporation (PAHC) Stock Analysis: Navigating Challenges with Growth in Animal Health Sector

Phibro Animal Health Corporation (NASDAQ: PAHC) stands as a notable player in the healthcare sector, specifically within the drug manufacturing industry focusing on specialty and generic products. Operating in key..

Search

Funds

September 12, 2025

Search

Funds

September 12, 2025

FTSE 100

Funds